Close Menu

The Scan

Watch It Go

The Wall Street Journal has put together maps of how SARS-CoV-2 has spread based on genetic mutations that have accrued in the virus.

Other Effects

BuzzFeed News reports that studies of rare genetic diseases have been affected by pandemic-related closures.

In Nature this week: combining genome-wide association and transcriptome study data homes in on cells involved in brain disorders, and more.

The Boston Globe reports Harvard University is paying $1.4 million to settle a claim that a former professor there overcharged work to US federal grants.

Found in the Air

A new study found SARS-CoV-2 genetic material within air samples from confined spaces and crowded areas, the New York Times reports.

From the Freezer

A Glasgow University-led team says the livestock-infecting bluetongue virus may have re-emerged through contaminated frozen stocks.

In Genome Biology this week: computational approach to determine phylogenetic relationships from single-cell data, metagenomic classification pipeline, and more.

New Scientist reports the names of the members of the Scientific Advisory Group for Emergencies that is advising the UK on its coronavirus response are to be released.

Funding Gone

According to Politico, a project studying how coronaviruses spread from bats to people has lost its federal US funding.

Lifespan Effects

Science reports that very rare genetic mutations in combination may take years off people's lives.

In PNAS this week: single-cell RNA sequencing study of pancreatic duct cells, sequencing of viruses affecting honey bees, and more.

Questions swirl regarding whether Alex Azar, the secretary of the Department of Health and Human Services, may soon be out of a job, the Wall Street Journal reports.

Politico reports the US Food and Drug Administration is dealing with a number of inaccurate tests for SARS-CoV-2 antibodies.

In a twin study, researchers find genetic factors account for half of the differences observed in COVID-19 symptoms, according to the Guardian.

In PLOS this week: genomic analysis of multidrug-resistant Mycobacterium tuberculosis strains from Colombia, inflammatory response signatures in cancer, and more.

Donald Kennedy Dies

Donald Kennedy, the former commissioner of the US Food and Drug Administration and the former editor-in-chief of Science, has died of COVID-19 at 88 years of age.

New York Governor Andrew Cuomo announced that an antibody survey of state residents found that SARS-CoV-2 infections may be more widespread than thought, the New York Times reports.

At the Economist and his own site, Bill Gates discusses the scientific advances needed to address the pandemic and what comes next.

In Science this week: expression of concern issued for paper on using circulating tumor DNA methylation profiles to diagnose colorectal cancer, and more.

Forced Out

Former BARDA chief Rick Bright tells the New York Times he was forced out because he pushed for strict testing of a coronavirus treatment touted by President Donald Trump.

Unfounded Rumor

Experts tell NPR that theories about a lab origin for SARS-CoV-2 are unfounded.

Just Use Your Phone

Researchers have developed a smartphone-powered device that can identify DNA in various sample types, New Scientist reports.

In Nature this week: watching TV may be a risk factor for coronary artery disease, genomes of five cotton species, and more.

Left BARDA Behind

Stat News reports Rick Bright is no longer the head of the Biomedical Advanced Research and Development Authority.

Swab from the Couch

LabCorp has received US Food and Drug Administration authorization for at-home sample collection for its COVID-19 test, 360Dx reports.

Pages

The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.

Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.

A new analysis finds a link between popular media coverage of a scientific study and how often that paper is cited.

In Nature this week: CRISPR approaches to editing plant genomes, way to speed up DNA-PAINT, and more.